Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday’s stock market.
Source: https://www.investors.com/stock-lists/new-highs/biotech-liga…
In this video, I will discuss two undervalued companies that have experienced a decent pullback in 2025 and expect to show fundamental improvements in 2026.
RELY, FTI, SHIP, AU and TPR stand out with strong relative price strength, rising earnings estimates and powerful one-year gains in a volatile 2026 market.
Dividends are a passive income stream, but they’re much more than that. They indicate a company’s respect for the shareholders and, when a business pays dividends for many years, it’s a sign of stability and reliability.
